![Derek Maetzold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek Maetzold
Fondateur chez
CASTLE BIOSCIENCES, INC.
Fortune : 5 M $ au 31/05/2026
Profil
Derek J.
Maetzold is the founder of Castle Biosciences, Inc., founded in 2007, where the title held is President, Chief Executive Officer & Director.
Current jobs include Director at AltheaDx, Inc. since 2021, Director at Prelude Corp.
since 2022, Director at Ocular Melanoma Foundation, and Director at IMPACT Melanoma, Inc. Former jobs include Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Education includes undergraduate studies at George Mason University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC. 0,84 % | 15/06/2026 | 253 861 ( 0,84 % ) | 5 M $ | 31/05/2026 |
Postes actifs de Derek Maetzold
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Fondateur | 01/09/2007 |
| ALTHEADX INC | Directeur/Membre du Conseil | 26/05/2021 |
Ocular Melanoma Foundation
 Ocular Melanoma Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable organization that provides eye cancer patient education and research funding services | Directeur/Membre du Conseil | - |
Prelude Corp.
 Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Directeur/Membre du Conseil | 02/02/2022 |
Anciens postes connus de Derek Maetzold
| Sociétés | Poste | Fin |
|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Sales & Marketing | 01/05/2008 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01/01/2003 |
Integrated Communications Corp.
 Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Creates ads for pharmaceutical companies | Corporate Officer/Principal | 01/01/1999 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Directeur/Membre du Conseil | 01/01/1998 |
Sandoz Pharmaceuticals Corp. | Sales & Marketing | 01/01/1996 |
Formation de Derek Maetzold
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
AltheaDx, Inc.
 AltheaDx, Inc. Medical SpecialtiesHealth Technology Operates as a commercial stage molecular diagnostics company | Health Technology |
Integrated Communications Corp.
Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Creates ads for pharmaceutical companies | Commercial Services |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals Corp. | |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Health Technology |
Ocular Melanoma Foundation
Ocular Melanoma Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable organization that provides eye cancer patient education and research funding services | Miscellaneous |
